With JPM 2022 having finished up last week, new standout partnerships between promising biotech companies and profitable big pharma show that reciprocity between players…

Synthetic biology is a new area of research and development that applies engineering principles to biological processes. Synthetic biology enables…

Demographically, South Korea has been an appealing investment opportunity for pharma companies. It has a relatively large population of around 51 million people…